Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization

Study ID
NCT02208804

Study type
Interventional

Study phase
Phase 2/Phase 3

Study status
Unknown status

Trial Acronym

SIM

Trial Summary

The objective of the SIM trial is to investigate whether using the Surefire Infusion System during holmium-166 radioembolization increases the posttreatment tumor to non-tumor activity concentration ratio, compared with using a standard end-hole microcatheter.

More informations

Trial Starting Date

Nov 30,2014

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit